Skip to content

Comparison of sufentanil and remifentanil in combination with propofol to facilitate use of supraglottic airway devices

Comparison of sufentanil and remifentanil in combination with propofol to facilitate use of supraglottic airway devices

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110027686N1
Enrollment
200
Registered
2011-12-31
Start date
2011-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal intubation. Failed or difficult intubation

Interventions

Intervention 1: General anesthesia was induced for all patients with 2.5 mg/kg of IV propofol in the first group and patients received 1 µg/kg remifentanil and LMA was used for airway management. Inte
Treatment - Drugs
General anesthesia was induced for all patients with 2.5 mg/kg of IV propofol in the first group and patients received 1 µg/kg remifentanil and LMA was used for airway management
General anesthesia was induced for all patients with 2.5 mg/kg of IV propofol in the second group and patients received 1 µg/kg remifentanil and SLIPA was used for airway management
General anesthesia was induced for all patients with 2.5 mg/kg of IV propofol in the third group and patients received 1.5 µg/kg remifentanil and LMA was used for airway management
General anesthesia was induced for all patients with 2.5 mg/kg of IV propofol in the fourth group and patients received 1.5 µg/kg remifentanil and SLIPA was used for airway management

Sponsors

Arak University of Medical Sciences,Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criterion: patients who were candidates for elective surgery Exclusion criteria: hemodynamic instability; history of heart and respiratory disorders; required airway control by endotracheal intubation and need to change position during surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: Before induction of anesthesia and one, three and five minutes after induction of anesthesia. Method of measurement: Blood pressure manometer.;Heart rate. Timepoint: Before induction of anesthesia and one, three and five minutes after induction of anesthesia. Method of measurement: Counting the heart rate in one minute.;Jaw Opening. Timepoint: One minute after induction of anesthesia. Method of measurement: variable was measured qualitatively by 3 grades: Full(3) Partial(2) Nil(1).;Ease of supraglottic device insertion. Timepoint: One minute after induction of anesthesia. Method of measurement: variable was measured qualitatively by 3 grades: Easy(1)Difficult(2)Impossible(3).;Cough. Timepoint: One minute after induction of anesthesia. Method of measurement: variable was measured qualitatively by 3 grades: Nil(1) ++(2) +++(3).;Laryngospasm. Timepoint: One minute after induction of anesthesia. Method of measurement: variable was measured qualitatively by 3 grades: Nil(1) Moderate(2) Vigorous(3).;Gagging. Timepoint: One minute after induction of anesthesia. Method of measurement: variable was measured qualitatively by 3 grades: Nil(1) ++(2) +++(3).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hesamaldin Modir

Arak University of Medical Sciences

dr.hemodir@arakmu.ac.ir+98 86 1313 9793

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026